Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Ting

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Irun Bhan, Tanya T Kwan, et al.
Annals of Surgery|January 20, 2015
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancerCristina R Ferrone, Giovanni Marchegiani, Theodore S Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment ResponseToni T Seppälä, Jacquelyn W Zimmerman, Reecha Suri, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumabRyan J Park, Milan Parikh, Leon Pappas, et al.
Theranostics|September 30, 2024
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studiesShadi A Esfahani, Hua Ma, Shriya Krishna, et al.
Cell Reports|September 23, 2014
Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cellsDavid T Ting, Ben S Wittner, Matteo Ligorio, et al.
Cancer Discovery|January 6, 2018
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate CancerDavid T Miyamoto, Richard J Lee, Mark Kalinich, et al.
The Journal of Clinical Investigation|June 16, 2022
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotypeRebecca L Porter, Siyu Sun, Micayla N Flores, et al.
Molecular Cancer Research : MCR|September 3, 2020
Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic CancerKim C Honselmann, Pascal Finetti, David J Birnbaum, et al.
Cancer Discovery|November 18, 2020
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Whijae Roh, Ryan J Sullivan, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Irun Bhan, Tanya T Kwan, et al.
Annals of Surgery|January 20, 2015
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancerCristina R Ferrone, Giovanni Marchegiani, Theodore S Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment ResponseToni T Seppälä, Jacquelyn W Zimmerman, Reecha Suri, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumabRyan J Park, Milan Parikh, Leon Pappas, et al.
Theranostics|September 30, 2024
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studiesShadi A Esfahani, Hua Ma, Shriya Krishna, et al.
Cell Reports|September 23, 2014
Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cellsDavid T Ting, Ben S Wittner, Matteo Ligorio, et al.
Cancer Discovery|January 6, 2018
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate CancerDavid T Miyamoto, Richard J Lee, Mark Kalinich, et al.
The Journal of Clinical Investigation|June 16, 2022
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotypeRebecca L Porter, Siyu Sun, Micayla N Flores, et al.
Molecular Cancer Research : MCR|September 3, 2020
Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic CancerKim C Honselmann, Pascal Finetti, David J Birnbaum, et al.
Cancer Discovery|November 18, 2020
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Whijae Roh, Ryan J Sullivan, et al.
Pageof 16